Category: Psychedelics

The Business of Cannabis by Extroverting

Massachusetts Recreational Marijuana Sales Hit $7 Billion Milestone, With Record-Breaking Seven-Month Surge, Officials Say

Massachusetts adult-use marijuana sales have officially exceeded $7 billion since the state’s legal market launched in 2018, regulators announced. And $1 billion of that total came in just seven months—marking a state record. The Massachusetts Cannabis Control Commission (CCC) said the state reached the $7 billion mark on November 19, eight days before the marijuana

MA by Extroverting
Read More

Growth of sports betting may be linked to financial woes, new studies find

By Kevin Hardy, Stateline.org While states have cheered the new tax revenue from sports gambling, some new studies have linked the burgeoning industry to lower consumer credit scores, higher credit card debt and less household savings. With access on their cellphones, gamblers can bet more often and easily than in traditional casinos, heightening concerns about

The Business of Cannabis by Extroverting
Read More

Relmada halts depression drug trials, shifts focus to psilocybin program amid review

Relmada Therapeutics Inc. (Nasdaq: RLMD) will halt its Phase 3 studies of depression treatment REL-1017 following a data monitoring committee evaluation, sending the company searching for strategic alternatives. The late-stage biotechnology company will discontinue both the Reliance II and Relight Phase 3 studies while continuing development of REL-P11, its modified …